Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Barrett Esophagus
Research on barrett esophagus described by scientists at University of Massachusetts
May 19th, 2009
According to a study from the United States, "Accurate diagnosis of dysplasia and adenocarcinoma in patients with Barrett esophagus is critical for clinical decision-making and patient management. IMP3 is all oncofetal protein and has been demonstrated to be associated with aggressive tumor behavior." "The ann of this study was to establish the expression pattern and diagnostic value of IMP3 in Barrett esophagus. dysplasia and carcinoma. A total of 217 cases (resection, n = 56: biopsy. n = 161) with 302 lesions (invasive esophageal adenocarcinoma. n = 147: metastatic esophageal adenocarcinoma, n = 14 high-grade dysplasia of the esophagus, n = 52; low-grade dysplasia of...
Source: Cancer Weekly (2009-05-19)
|
